-
New supplier SPI—advantageous supplier of excipients such as mannitol and sorbitol sorbitan solution
Time of Update: 2021-11-01
It is suitable for powder direct compression and dry granulation processes, and is commonly used in swallowing tablets, chewable tablets, orally disintegrating powders, effervescent tablets, lozenges and hard capsules .
-
A total of 242348657 confirmed cases of new crowns worldwide
Time of Update: 2021-11-01
WHO: The global cumulative number of confirmed cases of new crown reached 2,423,486,57 WHO: The global cumulative number of confirmed cases of new crown reached 2,423,48657 WHO: The
-
Viral infections are associated with neurodegenerative diseases
Time of Update: 2021-11-01
German scientists carried out a proof-of-concept study in mammalian cells and found that the virus surface helped them enter The glycoproteins of target cells may promote the proliferation of protein polymers in neurodegenerative diseases .
-
24 new confirmed cases on October 17th, 2 local cases
Time of Update: 2021-11-01
As of 24:00 on October 17, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 516 confirmed cases (including 1 severe case), a total of 91,394 cured and discharged cases, and a total of 4,636 deaths.
-
Pfizer, Roche, and Huizhi's structural changes attract attention!
Time of Update: 2021-11-01
Pfizer China replicates the global structure There are three main points of China's organizational reform announced by Pfizer this time: First, six independent business units were established, namely hospital emergency, tumor, rare diseases, inflammation and immunity, vaccines, and broad markets .
-
Health Commission: 43 new confirmed cases, 28 of which are in China
Time of Update: 2021-11-01
As of 24:00 on October 21, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 518 confirmed cases (including 3 severe cases), a total of 91,511 cured and discharged cases, and a total of 4,636 deaths.
-
National Health Commission: The virus in this round of the epidemic is a Delta mutant
Time of Update: 2021-11-01
CCTV News: State Council Wu Liangyou, deputy director of the Bureau of Disease Control and Prevention of the National Health Commission, said in response to a question from a reporter from the Central Station that the epidemic has spread in a wide range and is highly contagious .
Wu Liangyou introduced that the virus in the current epidemic was a delta mutant strain.
-
Experts break space barriers to realize a new model of off-site diagnosis and treatment of birth defects
Time of Update: 2021-11-01
Relying on this alliance, Huang Hefeng’s team has established a big data platform for related birth defects, drawn a map of common recessive pathogenic genes in the Chinese population, a new map of perinatal structural abnormalities, and a map of chromosome variation in the newborn population, providing detailed information for the diagnosis and treatment of birth defects.
-
National procurement has landed, the two provinces do not engage in "one size fits all", and the allocation ratio of unselected varieties in Shanghai is about 20%
Time of Update: 2021-11-01
On October 14th, Jiangsu Province issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", clarifying that the procurement price will be switched from the provincial platform at 24:00 on October 25; 24:00 on October 31 Start execution .
-
China's health level ranks fifth among upper-middle-income countries in the world
Time of Update: 2021-11-01
The Healthy China Index launched by the Xinhua News Agency News Information Center and the Shanghai Huaxia Social Development Research Institute is based on the health resources, health services, health protection, health environment, and health level.
-
Korsuva receives FDA approval to treat moderate to severe itching in patients with chronic kidney disease
Time of Update: 2021-10-23
▲Korsuva reached the primary endpoint in two key Phase 3 clinical trials (Image source: Cara Therapeutics official website)Korsuva is a "first-in-class" κ opioid receptor (KOR) agonist, which directly inhibits the activity of peripheral neurons that produce itching, so it can be used to relieve itching due to many reasons .
Retrieved August 23, 2021, from https:// news-release/2021/08/23/2285085/29236/en/Cara-Therapeutics-and-Vifor-Pharma-announce-US-FDA-approval-of-KORSUVA-difelikefalin-injection-for-the-treatment-of- moderate-to-severe-pruritus-in-hemodialysis-patients.
-
Four domestically produced PD-1s, ten new indications, and medical insurance negotiations are about to fall this year
Time of Update: 2021-10-23
In addition to the two included in medical insurance, BeiGene announced on January 14 this year that NMPA has approved its anti-PD-1 antibody tislelizumab combined with two chemotherapy regimens for the treatment of first-line advanced squamous non-small cell lung cancer (NSCLC).
-
Yahong Pharmaceutical was selected as one of the top 30 innovative small molecule drug companies in China
Time of Update: 2021-10-23
Adhering to the corporate mission of "improving human health and making life more dignified", Yahong is determined to become a leading international pharmaceutical company integrating R&D, production and commercialization in the field of focused treatment, providing the best integration of diagnosis and treatment for patients in China and around the world Solutions .
-
Plymouth's best-selling injections enter the UK!
Time of Update: 2021-10-23
On September 22, Puli Pharmaceuticals issued an announcement stating that it had recently received a marketing authorization for bivalrudine for injection issued by the British Medicines and Health Products Administration (MHRA), which indicated that the company has the qualification to sell the product in the UK .
-
Levofloxacin intermediates and APIs of East Asia Pharmaceuticals obtained EU registration certificate
Time of Update: 2021-10-23
On September 23, East Asia Pharmaceuticals announced that it had recently received the "Certificate of Applicability of the European Pharmacopoeia" issued by the European Medicines Quality Agency.
Levofloxacin intermediates and APIs have obtained EU registration certificates .
-
Yahong Pharma appoints Dr. Chen Yu as Vice President of Biological Research and Head of Translational Medicine Research of New Drug Discovery Department
Time of Update: 2021-10-23
Chen Yu will be responsible for and lead the biological research team to develop cutting-edge biotherapeutic technologies, new targets and mechanism research, and accelerate the promotion of new drug discovery projects .
-
Zhenhe Technology joins hands with Imona Medical to jointly develop mRNA tumor vaccines
Time of Update: 2021-10-23
Zhenhe Technology and Imona Medical will work together to break through technical bottlenecks, accelerate product development, and realize tumor vaccines based on tumor neoantigen + mRNA technology platform as soon as possible to serve the majority of tumor patients .
-
Oncolytic virus and PD-L1 inhibitor Roche reach clinical cooperation
Time of Update: 2021-10-23
Arthur Kuan, CEO of CG Oncology, said: "We are very pleased to combine the lead oncolytic immunotherapy CG0070 with atelizumab to evaluate their potential synergy in cancer in this important clinical trial .
-
Anke Biological Holding Subsidiary ZG033 Injection Drug Registration Application Accepted
Time of Update: 2021-10-23
At present, monoclonal antibodies and double antibodies targeting 4-1BB have shown their anti-tumor efficacy in preclinical or clinical trials.
-
Where is the next growth point in the sales of Bojian Alzheimer's disease new drug?
Time of Update: 2021-10-23
Due to the slow use of the Alzheimer's disease drug Aduhelm, Biogen may suffer a loss of US$20 billion .
Do not enter: Biogen reps banned from DC-area neurology clinics over controversial Alzheimer's drug Aduhelm
